Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes

Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes

Abstract The most common cause of end-stage renal disease (ESRD) and leading ultimately to hemodialysis (HD) is type 2 diabetes mellitus (T2DM). The current study aims to assess the role of serum urokinase plasminogen activator (UPA) levels among Iraqi hemodialysis patients with ESRD with type 2 dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatima Ali Essa Al-Sudani, Nawal Mohammed Jawad Al-Shammaa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Medical Journal of Babylon
Subjects:
creatinine
diabetes mellitus
kidney failure
lipid profile
urea
urokinase-type plasminogen activator
Online Access:https://doi.org/10.4103/MJBL.MJBL_777_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.4103/MJBL.MJBL_777_23

Similar Items